COVID-19 vaccination and DMTs in MS: What do we know so far?
The recent availability of multiple COVID-19 vaccines (against SARS-CoV-2) marked a turning point in the fight against the pandemic, but also raised some questions related to the management of chronic diseases like multiple sclerosis (MS).1 In this uncertain scenario, healthcare professionals (HCPs) are trying to find the right strategy to ensure optimal control of MS while consideri
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now